VITRASE (Bausch & Lomb Incorporated)
Welcome to the PulseAid listing for the VITRASE drug offered from Bausch & Lomb Incorporated. This Endoglycosidase [EPC],Glycoside Hydrolases [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Bausch & Lomb Incorporated |
| NON-PROPRIETARY NAME: | hyaluronidase, ovine |
| SUBSTANCE NAME: | HYALURONIDASE, OVINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Endoglycosidase [EPC],Glycoside Hydrolases [Chemical/Ingredient] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2005-02-01 |
| END MARKETING DATE: | 0000-00-00 |
VITRASE HUMAN PRESCRIPTION DRUG Details:
| Item Description | VITRASE from Bausch & Lomb Incorporated |
| LABELER NAME: | Bausch & Lomb Incorporated |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200([USP’U]/mL) |
| START MARKETING DATE: | 2005-02-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 24208-002_230ed4da-acbf-4cf5-9626-bff59c221007 |
| PRODUCT NDC: | 24208-002 |
| APPLICATION NUMBER: | NDA021640 |
Other HYALURONIDASE, OVINE Pharmaceutical Manufacturers / Labelers:
